SPYRE THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2023-12-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2023-12-11; Total offering amount $180,000,000.
- 2023-07-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2023-06-26; Total offering amount $210,000,248.
- 2015-03-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-03-10; Total offering amount $44,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2023-12-27 | Rule 506(b) | Equity | 2023-12-11 | $180,000,000 | $180,000,000 | $0 | 30 |
|---|
| 2023-07-06 | Rule 506(b) | Equity | 2023-06-26 | $210,000,248 | $210,000,248 | $0 | 41 |
|---|
| 2015-03-24 | Rule 506(b) | Equity | 2015-03-10 | $44,000,000 | $44,000,000 | $0 | 54 |
|---|